Synonyms: | |
Status: | Phase 3 |
Entry Type: | Small molecule |
Molecule Category: | Salt |
UNII: | 8A9H4VK35Z |
Parent Compound: | TIVOZANIB |
InChI Key | RQXMKRRBJITKRN-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C22H22Cl2N4O6 |
Molecular Weight | 509.35 |
AlogP | 5.64 |
Hydrogen Bond Acceptor | 7.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 6.0 |
Polar Surface Area | 107.74 |
Molecular species | NEUTRAL |
Aromatic Rings | 4.0 |
Heavy Atoms | 32.0 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Platelet-derived growth factor receptor beta inhibitor | FDA |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Liver Diseases | 1 | D008107 | ClinicalTrials |
Resources | Reference |
---|---|
ChEMBL | CHEMBL2105756 |
FDA SRS | 8A9H4VK35Z |
PubChem | 11547978 |
SureChEMBL | SCHEMBL21174286 |